Polymorphic Form I, II, III, IV and VI of 4 - trifluoromethyl - N - (3,3a, 4,4a, 5,5a, 6,6a - octahidro - 1.3 - - 4.6 - etenocicloprop f isoindol - 2 (1H) - yl) - benzamide (ST - 246); method for producing Pharmaceutical composition; Form; Dosing Unit; and Treatment method of orthopoxvirus Infections and Vaccinal eczema.

摘要

Polymorph forms of 4-trifluoromethyl-N-(3,3a,4,4a,5,5a,6,6a-octahydro-1,3-dioxo-4,6-ethenocycloprop[f]isoindol-2(1H)-yl)-benzamide are disclosed as well as their methods of synthesis and pharmaceutical compositions.